The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Open accessAbstract
BACKGROUND: Both the European Neuroendocrine Tumor Society (ENETS) and the International Union for Cancer Control/American Joint Cancer Committee/World Health Organization (UICC/AJCC/WHO) have proposed TNM staging systems for pancreatic neuroendocrine neoplasms. This study aims to identify the most accurate and useful TNM system for pancreatic neuroendocrine neoplasms. METHODS: The study included 1072 patients who had undergone previous surgery for their cancer and for which at least 2 years of follow-up from 1990 to 2007 was available. Data on 28 variables were collected, and the performance of the two TNM staging systems was compared by Cox regression analysis and multivariable analyses. All statistical tests were two-sided. RESULTS: Differences in distribution of sex and age were observed for the ENETS TNM staging system. At Cox regression analysis, only the ENETS TNM staging system perfectly allocated patients into four statistically significantly different and equally populated risk groups (with stage I as the reference; stage II hazard ratio [HR] of death = 16.23, 95% confidence interval [CI] = 2.14 to 123, P = .007; stage III HR of death = 51.81, 95% CI = 7.11 to 377, P < .001; and stage IV HR of death = 160, 95% CI = 22.30 to 1143, P < .001). However, the UICC/AJCC/WHO 2010 TNM staging system compressed the disease into three differently populated classes, with most patients in stage I, and with the patients being equally distributed into stages II-III (statistically similar) and IV (with stage I as the reference; stage II HR of death = 9.57, 95% CI = 4.62 to 19.88, P < .001; stage III HR of death = 9.32, 95% CI = 3.69 to 23.53, P = .94; and stage IV HR of death = 30.84, 95% CI = 15.62 to 60.87, P < .001). Multivariable modeling indicated curative surgery, TNM staging, and grading were effective predictors of death, and grading was the second most effective independent predictor of survival in the absence of staging information. Though both TNM staging systems were independent predictors of survival, the UICC/AJCC/WHO 2010 TNM stages showed very large 95% confidence intervals for each stage, indicating an inaccurate predictive ability. CONCLUSION: Our data suggest the ENETS TNM staging system is superior to the UICC/AJCC/WHO 2010 TNM staging system and supports its use in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
ANew Look at the Statistical Model Identification
AKAlKE, H. (2011) · Cited by 4,177
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationTNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationHistological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Self-citationNANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Self-citationWHO Classification of Tumours: An Overview
Yakin, M., & Logan, R. (2025) · Pathological Basis of Oral and Maxillofacial Diseases · doi:10.1002/9781119989233.ch26 · Cited by 555
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Missiaglia, E., Dalai, I., Barbi, S., Beghelli, S., Falconi, M., della Peruta, M., Piemonti, L., Capurso, G., Di Florio, A., delle Fave, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5988 · Cited by 536
Self-citationFynn, R. W. (1959) · PubMed · Cited by 502
Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D
Newson, R. B. (2010) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1001000303 · Cited by 424
Scarpa, A., Mantovani, W., Capelli, P., Beghelli, S., Boninsegna, L., Bettini, R., Panzuto, F., Pederzoli, P., Fave, G. D., & Falconi, M. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.58 · Cited by 422
Self-citationCancer: Principles and Practice of Oncology
Gunn, W. G. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440160120054 · Cited by 407
Pape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Self-citationHruban, R. H., Pitman, M. B., & Klimstra, D. S. (2007) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/9781933477022 · Cited by 370
Ekeblad, S., Skogseid, B., Dunder, K., Öberg, K., & Eriksson, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0734 · Cited by 360
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
Modlin, I. M., Moss, S. F., Chung, D. C., Jensen, R. T., & Snyderwine, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn275 · Cited by 224
Bettini, R., Boninsegna, L., Mantovani, W., Capelli, P., Bassi, C., Pederzoli, P., Delle Fave, G. F., Panzuto, F., Scarpa, A., & Falconi, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm552 · Cited by 213
Self-citationNeuroendocrine neoplasms of the gut and pancreas: new insights
Rindi, G., & Wiedenmann, B. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.120 · Cited by 191
Self-citationLa Rosa, S., Klersy, C., Uccella, S., Dainese, L., Albarello, L., Sonzogni, A., Doglioni, C., Capella, C., & Solcia, E. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.06.005 · Cited by 174
Self-citationKircher, C. H., & Nielsen, S. W. (1976) · Europe PMC (PubMed Central) · Cited by 117
Öberg, K., & Jelić, S. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp158 · Cited by 82
Neuroendocrine Neoplasms of the Pancreas
Markow, M., & Centeno, B. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_13 · Cited by 74
Öberg, K., & Jelic, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn117 · Cited by 35
Pancreatic Neuroendocrine Tumors
Balachandran, A., Fleming, J. B., Callender, G. G., Krishnan, S., & Yao, J. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2232-1.00013-9 · Cited by 9
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Self-citationPavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationGarcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., et al. (2016) · Neuroendocrinology · doi:10.1159/000443172 · Cited by 611
Self-citationGastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Metadata
- Authors
- Rindi, G., Falconi, M., Klersy, C., Albarello, L., Boninsegna, L., Buchler, M. W., Capella, C., Caplin, M., Couvelard, A., Doglioni, C., Delle Fave, G., Fischer, L., Fusai, G., de Herder, W. W., Jann, H., Komminoth, P., de Krijger, R. R., La Rosa, S., Luong, T. V., Pape, U., Perren, A., Ruszniewski, P., Scarpa, A., Schmitt, A., Solcia, E., & Wiedenmann, B.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-23
- Volume
- 104
- Issue
- 10
- Pages
- 764-777
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2139082628
- Cited by
- 452
- References
- 31
- FWCI
- 29.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.